USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable […]
Loop Genomics deploys new sequencing technology and protocols to provide unparalleled insight into microbiome research San Jose, CA – Loop Genomics, the single molecule long-read sequencing company with a hardware free solution, has expanded its kit and services capabilities to provide researchers with new ultra-high resolution Microbiome sequencing solutions using long-reads on Illumina sequencers. The […]
Today Genovis expands its portfolio of glycan specific enzymes with the launch of SialEXO 23. A new member of the SialEXO family, SialEXO 23 is an enzyme for study of a specific type of sugar on biopharmaceuticals. Most biopharmaceutical drugs are glycoproteins and the glycan composition is of interest to biopharma companies since it can impact the function and half-life of a particular therapeutic. The […]
Additional distributors provide scientists working in drug screening, cancer research, 3D cell models and toxicology with the ability to improve the human relevance of in vitro cell models NEW YORK — Xylyx Bio, a pioneer in physiomimetic cell culture, today announced that it is expanding globally to meet growing international demand for its physiologic cell culture products. The […]
NEWARK, Calif., & QUEBEC CITY–ATUM, a Newark, California-based leader in the development of protein expression technologies, announced today the exclusive licensing of gene-coding algorithm GeneGPS® to optimize protein expression in Nicotiana benthamiana to Medicago, a global leader in the development and production of plant-derived vaccines and therapeutic proteins. The gene design technology was developed using ATUM’s patented gene […]
Addressing a billion-dollar market with innovative technologies which remove bottlenecks in research and discovery Heidelberg, Germany and Cambridge, UK – CaptSure™ DIY ELISA will complement Expedeon AG’s product offering, as the Company (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) announced today. The technology was developed by TGR BioSciences, which was acquired by Expedeon in May 2018. CaptSure DIY […]
Announcing the CloneSelect™ Single-Cell Printer™ Series. Eyewitness proof of monoclonality. SAN JOSE, Calif. — Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced an expansion in its partnership with cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ Series in North America. Building on their success of the CloneSelect™ Single-Cell Printer™ SCP™ system, the new family evolves both the […]
SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it appointed Nelson C. Chan, former CEO of Magellan, as a Class I director to its board of directors. Mr. Chan brings more than 35 years of experience as both […]
Student-led experiment edits yeast genes to study DNA repair in space Cambridge, MA – For the first time, astronauts have used CRISPR/Cas9 technology to edit DNA in space. The gene editing technique was deployed on the International Space Station (ISS) to induce targeted breaks in the yeast genome. Molecular changes left behind as yeast repair these breaks […]
AMSBIO introduces StemFit® Basic04, a next generation feeder-free medium for the maintenance of Induced Pluripotent Stem (iPS) and Embryonic Stem (ES) cells during the reprogramming, expansion and differentiation phases of stem cell culture. With its fully defined and animal-origin free formulation, StemFit® Basic04 is suited to both research studies and translation to cell therapy. With […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
